设计公平:评估马达加斯加南部零剂量减少努力的评估框架
Guillaume Demare1, Elgiraud Ramarosaiky2, Zavaniarivo Rampanjato2
1Center for Global Health, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
Vaccines
|August 28, 2025
概括
这项研究评估了马达加斯加的SOAMEVA计划,该计划针对零剂量 (ZD) 的儿童,以提高免疫公平性. 该计划使用以社区为基础的策略和以公平为基础的评估设计,以达到服务不足的人群.
科学领域:
- 全球健康
- 公共卫生
- 疫苗接种计划
背景情况:
- 持续存在的不平等现象阻碍了全民接种疫苗,
- 马达加斯加的常规疫苗接种率很低,特别是在服务不足的地区.
- 针对16个南部地区的零剂量儿童.
研究的目的:
- 概述SOAMEVA计划的股权敏感评估设计.
- 评估一个以社区为基础的倡议的实施和影响.
- 在脆弱环境中确定公平免疫计划评估的原则.
主要方法:
- 综合量化计划监测和社区的定性洞察力.
- 在Fokontany (最小的行政单位) 层面进行集中评估,以捕捉微小层面的差异.
- 与社区卫生工作者和护理人员建立了结构化的反循环.
主要成果:
- 评估设计捕捉了ZD患病率和计划范围的小规模变化.
- 通过社区反识别免疫接种和计划采用的当地障碍.
- 在不同背景下跟踪实时调整实施策略.
结论:
- 一个公平的评估框架对于了解和改善服务不足地区的免疫计划至关重要.
- 基于社区的方法和当地洞察力提高了方案的响应性,可持续性和公平性.
- 提出了八个设计原则,以公平评估脆弱环境中的免疫计划.
相关概念视频
Bioavailability Study Design: Single Versus Multiple Dose Studies
380
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
380
Dosage Regimens: Designs and Approaches
598
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
598
Dosage Regimen Designs: Nomograms and Tabulations
353
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
353
Dose Size and Dosing Frequency: Determination Methods
802
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
802
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
383
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
383
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
394
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
394


